首页 | 本学科首页   官方微博 | 高级检索  
检索        

离心造粒法制备托拉塞米缓释小丸胶囊及其释放度考察
引用本文:谢燕萍.离心造粒法制备托拉塞米缓释小丸胶囊及其释放度考察[J].中国药师,2011,14(3):391-394.
作者姓名:谢燕萍
作者单位:佛山市第一人民医院,广东佛山,528000
摘    要:目的:制备托拉塞米缓释小丸胶囊。方法:采用离心造粒粉末层积法制备托拉塞米小丸,用丙烯酸树脂水分散体包衣,并对包衣小丸的释药特征进行探讨。结果:微晶纤维素(MCC)空白母核32~40目的收率约80.2%,含药素丸20~24目收率约87.6%,使用Eudragit NE30D包衣液,包衣增重10%。托拉塞米缓释胶囊体外释药行为较好地符合Higuchi方程。结论:在优化的工艺条件下可制得表面光滑、圆整度高的托拉塞米缓释小丸。

关 键 词:托拉塞米  缓释小丸  离心造粒法  体外释放度

Studies on Preparation of Torasemide Sustained-Release Pellets Capsules by Centrifugal Granulator and Release Behavior in vitro
Xie Yanping.Studies on Preparation of Torasemide Sustained-Release Pellets Capsules by Centrifugal Granulator and Release Behavior in vitro[J].China Pharmacist,2011,14(3):391-394.
Authors:Xie Yanping
Institution:Xie Yanping(Foshan First Hospital,Guangdong Foshan 528000,China)
Abstract:Objective:To prepare torasemide sustained-release pellets capsules.Method:Torasemide sustained-release pellets capsules were prepared by powder layering technique in a centrifugal granulation equipment and coated with Eudragit NE30D.The release mechanism was also studied in vitro.Result:The yield of core pellets prepared with MCC was 80.2%(32-40 mesh),and the yield of drug pellets was 87.6%(20-24 mesh).The coating fluid was Eudragit NE30D with coating weight gain of 10%.The preparation had good sustained re...
Keywords:Torasemide  Sustained-release pellets  Centrifugal granulator  Release rate in vitro  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号